Therefore, orexin A also plays a key role in promoting neurological improvement through pathways other than the inhibition of atherosclerosis in AIS patients (Sikder & Kodadek, 2007; Xu et al., 2021). Here, HCRT is linked to androgen insensitivity syndrome.